Data Collective IV GP, LLC Long-Term Concentrated

CIK: 0001664974 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 14, 2024

Total Value ($000): $120,885 (100.0% shares, 0.0% debt)

Holdings (5)

RXRX Recursion Pharmaceuticals, Inc. 48.5%

Value ($000) $58,579 Shares 5,941,120 Est. Cost $18.82 Unrealized -62.1%

EVLV Evolv Technologies Holdings, Inc. 37.8%

Value ($000) $45,696 Shares 9,681,281 Est. Cost $5.61 Unrealized -23.8%

— Rocket Lab USA, Inc. 13.4%

Value ($000) $16,199 Shares 2,929,350 Est. Cost $4.04 Unrealized —

— Mind Medicine (MindMed) Inc. 0.3%

Value ($000) $367 Shares 100,350 Est. Cost $3.17 Unrealized —

ROIV Roivant Sciences Ltd. 0.0%

Value ($000) $44 Shares 3,875 Est. Cost $5.56 Unrealized +75.2%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
RXRX	Recursion Pharmaceuticals, Inc.	5,941,120	$58,579	48.5%	$18.82	-62.1%	CL A	75629V104
EVLV	Evolv Technologies Holdings, Inc.	9,681,281	$45,696	37.8%	$5.61	-23.8%	COM CL A	30049H102
—	Rocket Lab USA, Inc.	2,929,350	$16,199	13.4%	$4.04	—	COM	773122106
—	Mind Medicine (MindMed) Inc.	100,350	$367	0.3%	$3.17	—	COM NEW	60255C885
ROIV	Roivant Sciences Ltd.	3,875	$44	0.0%	$5.56	+75.2%	SHS	G76279101